Ping An Healthcare and Technology Company Limited
PIAHY · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 6.21B | 1.67B | -726.34M | -636.06M | -1.18 |
| 2023 FY | 4.67B | 1.51B | -575.26M | -322.59M | -0.60 |
| 2024 FY | 4.81B | 1.52B | -89.06M | 81.43M | 0.14 |
| 2025 FY | 5.32B | 1.72B | 182.49M | 369.17M | 0.36 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 17.14B | 3.68B | 3.70B | 176.49M | 13.46B |
| 2023 FY | 16.52B | 3.25B | 1.87B | 93.61M | 13.28B |
| 2024 FY | 16.78B | 13.20B | 2.04B | 45.00M | 3.59B |
| 2025 FY | 13.24B | 3.33B | 2.40B | 39.82M | 9.92B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -810.62M | -34.44M | -845.05M | — | 635.81M |
| 2023 FY | -282.86M | -42.96M | -325.82M | — | -1.83B |
| 2024 FY | 99.33M | -34.24M | 65.09M | — | 178.14M |
| 2025 FY | 430.11M | -38.84M | 391.28M | -3.80B | 343.09M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 20.87B | 17.35B | — | — | — |
| 2023 FY | 18.28B | 16.51B | — | — | — |
| 2024 FY | 8.27B | 6.27B | — | — | — |
| 2025 FY | 26.70B | 24.34B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2024 Q2 | 2.09B | 673.80M | -41.52M | 56.65M | 0.10 |
| 2024 Q4 | 2.71B | 849.56M | -47.55M | 24.78M | 0.04 |
| 2025 Q2 | 2.50B | 839.71M | 86.74M | 134.16M | 0.14 |
| 2025 Q4 | 2.91B | 915.34M | 10.66M | 240.82M | 0.22 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2024 Q2 | 16.20B | 2.83B | 3.01B | 59.25M | 13.38B |
| 2024 Q4 | 16.78B | 13.20B | 2.04B | 45.00M | 3.59B |
| 2025 Q2 | 12.95B | 3.26B | 2.85B | 45.97M | 9.70B |
| 2025 Q4 | 13.24B | 3.33B | 2.40B | 39.82M | 9.92B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2024 Q2 | -135.01M | -10.54M | -145.54M | — | 3.01B |
| 2024 Q4 | 234.34M | -23.71M | 210.63M | — | -964.00M |
| 2025 Q2 | 63.56M | -3.58M | 59.98M | -3.91B | 2.85B |
| 2025 Q4 | 322.07M | -35.73M | 286.34M | -68.99M | -694.87M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2024 Q2 | 10.95B | 8.00B | — | — | — |
| 2024 Q4 | 8.27B | 6.27B | — | — | — |
| 2025 Q2 | 16.31B | 13.50B | — | — | — |
| 2025 Q4 | 27.59B | 25.23B | — | — | — |